AstraZeneca's combo lung disease therapy falls short of FDA approval

The U.S. Food and Drug Administration declined to approve AstraZeneca Plc's combo therapy to treat a form of lung disease, the drugmaker said on Tuesday.


from Reuters: Health News https://ift.tt/2nmOODc

Comentarii

Postări populare de pe acest blog

The Best Food, Drink, and Home Service Subscriptions to Give as Wedding Gifts

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

Telehealth hubs offer care options for people living on the edge the virtual world